Patents Assigned to AVAXZIPEN LIMITED
  • Patent number: 12364665
    Abstract: The present disclosure relates to solid dose formulations for needle-free delivery comprising 0.01 to 60 (w/w) of one or more therapeutic agent and/or prophylactic agent; and 40.0% to 99.99% (w/w) of dextran. The invention further concerns methods of producing a solid dose formulation tablet and application its particular medical uses, in particular as a vaccine.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: July 22, 2025
    Assignee: AVAXZIPEN LIMITED
    Inventors: David Andrew Grant, Chris MacGregor
  • Patent number: D982744
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: April 4, 2023
    Assignee: AVAXZIPEN LIMITED
    Inventors: Owen Ryan, David Andrew Grant, Ritwik